Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone

BACKGROUND: This study aimed to investigate copy number variations (CNVs) of CYP17A1 and androgen receptor (AR) genes in serum cell-free DNA collected before starting abiraterone in 53 consecutive patients with castration-resistant prostate cancer (CRPC). METHODS: Serum DNA was isolated and CNVs wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvi, S, Casadio, V, Conteduca, V, Burgio, S L, Menna, C, Bianchi, E, Rossi, L, Carretta, E, Masini, C, Amadori, D, Calistri, D, Attard, G, De Giorgi, U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430717/
https://www.ncbi.nlm.nih.gov/pubmed/25897673
http://dx.doi.org/10.1038/bjc.2015.128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430717/
https://www.ncbi.nlm.nih.gov/pubmed/25897673
http://dx.doi.org/10.1038/bjc.2015.128

Ejemplares similares